Surge in Open Interest Signals Shift in Market Dynamics for Alkem Laboratories
Alkem Laboratories Ltd has seen a significant rise in open interest, reaching 16,948 contracts, alongside a trading volume of 27,604 contracts. Despite this increase, the stock has underperformed compared to its sector, with a notable decline in its intraday price and mixed performance against various moving averages.
Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 16,948 contracts, reflecting a notable rise of 4,463 contracts or 35.75% from the previous open interest of 12,485. This surge in open interest comes alongside a trading volume of 27,604 contracts, indicating heightened activity in the stock.Despite this increase in open interest, Alkem Laboratories has underperformed relative to its sector, with a 1D return of -3.68%, compared to a sector return of -0.30%. The stock opened with a loss of 3.48% today, reaching an intraday low of Rs 5,043.5, which represents a decline of 4.74%. The weighted average price suggests that more volume was traded closer to this low price point.
In terms of moving averages, the stock is currently above the 50-day and 100-day moving averages but below the 5-day, 20-day, and 200-day averages. The liquidity remains robust, with a delivery volume of 59.29k on May 29, reflecting an 18.61% increase against the 5-day average delivery volume. Overall, the notable spurt in open interest highlights a shift in market dynamics for Alkem Laboratories, amidst a challenging trading environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
